Stay updated on SPR1NT Clinical Trial
Sign up to get notified when there's something new on the SPR1NT Clinical Trial page.

Latest updates to the SPR1NT Clinical Trial page
- Check5 days agoChange DetectedThe page has removed an erratum related to the clinical trial and postmarketing safety of Onasemnogene Abeparvovec Therapy.SummaryDifference0.3%
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check27 days agoNo Change Detected
- Check34 days agoChange DetectedThe webpage has undergone significant updates, including the addition of new identifiers and collaborators related to the study of Spinal Muscular Atrophy (SMA), while extensive details about the study's methodology and inclusion/exclusion criteria have been removed.SummaryDifference35%
- Check42 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check49 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.1%
- Check85 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference1%
Stay in the know with updates to SPR1NT Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SPR1NT Clinical Trial page.